Ablesen
Ablesen provides the NACOTS medical device for healthcare providers to enable early and cost-effective disease detection.
ablesen.my/Industry
Healthcare > Diagnostics
Company Type
Product-Led Startup/Scaleup
Technology
IoT
biosensors
genetic testing
cloud data analysis
medical devices
About Ablesen
Ablesen manufactures NACOTS, a handheld medical device that utilizes IoT, circuitry, and biomedicine for the early detection of genetic diseases and cancer indicators. The device offers a cost-effective and non-invasive alternative to traditional lab testing, providing rapid results from blood samples. Ablesen aims to improve early intervention for critical conditions like breast cancer and COVID-19 by making advanced diagnostics more accessible.
Founded
1
Company Age
2025 years
Location
Shah Alam, Selangor
Malaysia
Company Size
2-10 employees